LASAK s.r.o.

Over 25 years, the research and development of bioactive materials for bone-tissue replacement has been carried out systematically at LASAK in co-operation with universities, research institutes and major clinics in the Czech Republic and abroad. Results of the research have then been used in the development of new products, which successfully entered the market. These products are now widely used in clinical practice, especially in the fields of dental implantology, maxillofacial surgery, orthopedics, neurosurgery, as well as in other fields. An important product line consists of resorbable and nonresorbable materials for bone regeneration, under the brands PORESORB-TCP and OssaBase-HA.

Significant progress has been achieved by the development of surface-treated bioactive titanium, which exhibits unique properties enabling faster, safer and more predictable implant healing. The first hydrophilic, bioactive surface treatment of implants was launched to the European market by LASAK in 2000. This new biomaterial has been successfully used in the production of dental (BioniQ and IMPLADENT) and spinal (IMPLASPIN) titanium implants.

The development results and clinical evaluations are widely documented in a number of research and clinical studies published in professional journals, conference proceedings and monographs.

The products are appreciated in more than 20 countries.